Pace Ventures
Venture capitalBerlin · Pre-Seed–Series A · 3 people tracked
Investment thesis
Pace Ventures focuses on two interconnected global challenges: human illness and climate change, believing that people thrive only when their health and environment are in balance. The firm invests as a co-lead or follower in health-tech and industrial-tech startups, predominantly in Europe and the US, at Pre-Seed and Seed stages. It emphasizes hands-on founder support, likening an investment to a marriage, and prides itself on making game-changing commercial and financial introductions.
Source: firm website, verified Aug 3, 2026.
Team · 3 people
from public directoriesWhat they invest in
from 13 of 18 portfolio companiesHealthtech ×6AI & Machine Learning ×5Biotech ×5Deep Tech ×5Cleantech ×4Climate Tech ×3Energy ×3Digital Health ×2
HQs:United States×6Germany×1United Kingdom×1Latvia×1
Investments · 18 tracked
founders shown can be your intro pathAerones provides robotic inspection, cleaning, coating, and repair services for wind turbine blades.
Advanced ManufacturingCleantechClimate TechDeep TechEnergyRoboticsRiga, LV
Dainis Kruze(Founder/CEO)inJanis Putrams(Founder/CTO)inNIGEL MCCLEAVE(Director)DAINIS KRUZE(Executive Officer, Director)JANIS PUTRAMS(Director)PHILIPP GOEHRE(Director)
PartnerMarius Swart· solo GP
Bitfount provides a federated AI and analytics platform that lets trial sponsors, CROs, clinics, hospitals and AI developers run algorithms on imaging and EHR data behind the firewall without extracting or sharing the data.
AI & Machine LearningDigital HealthHealthtech
PartnerMarius Swart· solo GP
Cellbyte automates regulatory workflows and data analysis for pharmaceutical drug launches, helping manufacturers prepare treatments for global markets faster.
AI & Machine LearningEnterprise SoftwareHealthtechMedical DevicesSaaSMunich, DE
Felix Steinbrenner(Co-Founder & CEO)inDanielSamuel
PartnerMarius Swart· solo GP
ChemFinity develops advanced chemical separation technologies for recovering critical minerals and other resources.
CleantechDeep TechNew MaterialsBrooklyn, US
Adam Uliana(Executive Officer, Director)Ever Velasquez(Director)
PartnerMarius Swart· solo GP
PartnerMarius Swart· solo GP
Creasallis develops CreaTap, a patented "plug-and-play" antibody modification technology that improves the penetration of antibody-based drugs into solid tumours, applicable to monoclonal, bispecific, and antibody-drug conjugates.
Biotech
Zahra Jawad(Founder)
PartnerMarius Swart· solo GP
PartnerMarius Swart· solo GP
Claymont, US
Grant Aarons(Executive Officer, Director, Promoter)Ferdinando Randisi(Director)Robert Kniaz(Director)
BoardSiraj Khaliq(Director)
PartnerMarius Swart· solo GP
Holobiome is a biotechnology company focused on the gut microbiome and its connection to the nervous system, working in areas such as microbiology, computational biology, and neuroscience.
AI & Machine LearningBiotechHealthtechBoston, US
Philip Strandwitz(Co-founder & Director, Chief Executive Officer)Iain Chessell(Director)Michael LaFleur(Executive Officer)Kim Lewis(Co-founder, Director)Mike La Fleur(President, Co-founder, Director)
BoardJoan LaRovere(Director)
PartnerMarius Swart· solo GP
Metri is a biotech company developing first-in-class, disease-modifying therapeutics for endometriosis and other uterine diseases originating in the endometrium.
BiotechFemTechHealthtech
PartnerMarius Swart· solo GP
Neurable develops brain-computer interface (BCI) technology via smart headphones designed to enhance employee focus, productivity, and well-being in corporate settings.
AI & Machine LearningDeep TechHardwareHealthtechHR TechAnn Arbor, US
Dr. Ramses Alcaide(CEO and Co-Founder)Michael Thompson(Executive Officer)Adam Eizenberg-Molnar(Cofounder)
PartnerMarius Swart· solo GP
PartnerMarius Swart· solo GP
Prenostics develops a blood test to detect the earliest stages of cancer (stages 0-2), earlier than current methods, aiming to enable curative treatment.
BiotechDigital HealthHealthtech
Sarah Blagden(Founder & CSO)
PartnerMarius Swart· solo GP
Project Omega recycles spent nuclear fuel to rebuild the domestic nuclear fuel cycle, using chemistry processing to remove key isotopes and develop new products for the nuclear economy.
Deep TechDefense TechEnergy
Staff Sheehan(CEO)
PartnerMarius Swart· solo GP
Ternary Therapeutics designs small molecule drugs called molecular glues using AI and physics-based modeling to enable protein interactions for treating diseases including cancer and arthritis.
AI & Machine LearningBiotechDeep Tech
PartnerMarius Swart· solo GP
Turnover Labs builds a durable electrolysis system that converts dilute CO2 emissions into pure, high-value chemical products on-site at any scale.
CleantechClimate TechNew Materials
Marissa Beatty(Founder & CEO)
PartnerMarius Swart· solo GP
Vema Hydrogen develops Engineered Mineral Hydrogen (EMH), a patented production method that stimulates naturally occurring subsurface geochemical reactions in ophiolite and BIF rock formations to produce carbon-free hydrogen at under $1/kg.
CleantechClimate TechEnergy
Pierre Levin(CEO)Florian Osselin(Inventor of Engineered Mineral Hydrogen)Colin McCulley(Director of Operations)
PartnerMarius Swart· solo GP
PartnerMarius Swart· solo GP
Portfolio news
latest coverage across their companiesNeurable · businesswire.com · Apr 28, 2026
Cellbyte · healthcareittoday.com · Dec 15, 2025
Aerones · finsmes.com · Jun 4, 2025
Frequently asked questions
- What stage does Pace Ventures invest at?
- Pace Ventures invests at the Pre-Seed, Seed, Series A stages.
- What is Pace Ventures's typical check size?
- Pace Ventures typically writes checks of $550K – $1.6M.
- What sectors does Pace Ventures focus on?
- Pace Ventures focuses on Advanced Manufacturing, Cleantech, Climate Tech, Deep Tech, Energy, Healthtech, New Materials.
- Where is Pace Ventures located?
- Pace Ventures is headquartered in Berlin, DE.
- Does Pace Ventures lead rounds?
- Yes, Pace Ventures leads investment rounds.
Images
Similar investors
Giant Ventures is a venture capital firm investing across sectors including AI, climate, health, energy and fintech, and also incubates some of its own companies. Its portfolio spans roughly 48+ companies across the US and Europe.
Industrifonden is a venture capital fund that backs transformative, scalable innovations aimed at improving society, partnering with founders across life science, deeptech, and industrial technology sectors.
Unruly Capital is a venture firm that backs founders working on ideas that seem too early or unconventional but are expected to become mainstream within a decade, focusing on frontier technology themes.
UntroD Capital is a deep-tech-focused investment firm that backs research-and-development-driven startups whose innovative technologies address challenges facing the planet and humanity, an approach it terms 'Real Tech'.
Clave is a private equity/venture capital manager with 20 years of experience and more than 90 investments made, actively participating in the strategy and management of its portfolio companies.






